This series of promotional meetings has been developed by AstraZeneca and OmniaMed SB. AstraZeneca has fully funded the meetings and is responsible for the content, logistics, and selection of speakers. OmniaMed SB has provided support. This Primary Care meeting is intended for HCPs in the following roles only: Doctors, Nurses, Specialist Nurses, Pharmacists, Dietitians, NHS Medicines Management and Clinical Commissioning professionals. This invitation is non-transferable to any other HCP roles.
Partnering for progress in type 2 diabetes: Exploring patient engagement in primary care
MEET THE SPEAKERS
- Kevin Fernando, GPwSI Diabetes and Medical Education, North Berwick
- Debbie Hicks, Nurse Consultant (Diabetes), Enfield
- Partha Kar, Consultant in Diabetes & Endocrinology, Southampton
- Jen Nash, Clinical Psychologist and Chartered Associate Fellow of the British Psychological Society, London
- Philip Newland-Jones, Consultant Pharmacist for Diabetes & Endocrinology, Southampton
- Fixing Dad
Kevin Fernando is a part-time GP Partner working at the coalface in North Berwick Health Centre, near Edinburgh. Kevin is a Primary Care Diabetes Society Committee member and a RCGP Clinical Advisor for diabetes & multi-morbidity. He was previously a Diabetes UK Clinical Champion. Kevin is also a writer and presenter for the NB Medical Education Hot Topics GP Update courses.
Kevin graduated from Edinburgh University in 2000 and holds both MRCGP and MRCP (UK) affiliations. He has completed a Master’s degree in diabetes, passed with distinction.
Kevin has been elected to Fellowship of both the Royal College of General Practitioners and the Royal College of Physicians of Edinburgh for his work in diabetes and medical education.
Debbie Hicks, Nurse Consultant – Diabetes MSc, BA, RGN, NMP, DN Cert, PWT Cert Barnet, Enfield and Haringey Mental Health Trust
Debbie began in diabetes nursing in 1990 where she developed the Diabetes Specialist Nursing Service in Hull from being a lone practitioner to being the lead DSN with seven other DSN colleagues.
In September 2005 she moved south to take up the post of Nurse Consultant – Diabetes. She leads a team of four nurses and two administrative staff. The role of the Enfield Intermediate Diabetes Nursing team is to provide high-quality, patient-centred diabetes care based within the community. Education is provided for both people with diabetes and healthcare professionals, and support is given to practice-based teams to provide structured diabetes care for their patients.
She has been involved in various national groups, including as the Chair of the Diabetes Nursing Strategy Group. She was Chair of the National Nurse Consultant Group from 2012 – 2014.
Debbie has published over a hundred and thirty papers in the UK, Italy, France and the United States, with eighty as first author, since she began in diabetes nursing in 1990. Topics of publication include insulin therapy, injection device choice, injection technique, blood glucose monitoring, care delivery, patient education, service redesign and many more. She has presented papers in the UK, Belgium, Norway, New Zealand, Israel, Switzerland and the Republic of Ireland.
Debbie was a member of the editorial board of the Journal of Diabetes Nursing since it was first published in 1996 and included her “Diabetes Issues” problem page. She was the Editor-in-Chief from 2007 until November 2017.
Debbie is a founding member and Co-Chair of TREND-UK (Training, Research and Education for Nurses in Diabetes-UK) that was launched in January 2010. TREND-UK published the 4th Edition of An Integrated Career and Competency Framework for Diabetes Nursing in October 2015. In 2009 Debbie started the Forum for Injection Technique UK. She is Chair of FIT UK, which aims to encourage best practice in injection technique for all healthcare professionals and people with diabetes using injectable therapies globally to ensure optimum benefit from these medications. In 2013 Debbie won two National awards for her work on injection safety.
She still finds diabetes nursing challenging, stimulating and highly rewarding even after 27 years.
Dr Partha Kar has been a Consultant in Diabetes & Endocrinology at Portsmouth Hospitals NHS Trust since 2008. He has been the Clinical Director of Diabetes from 2009-2015, being part of a multiple national award-winning department (HSJ Awards / BMJ Awards) due to its services and care provided.
One of his main areas or passion is in helping to redesign diabetes care in an attempt to integrate chronic disease management across primary and secondary care. He is the pioneer of the Super Six Diabetes Model which aims to deliver diabetes care differently. He is an avid user of social media such as twitter (@parthaskar) to engage with patients - and been recognised as a "Social media Pioneer" by HSJ in 2014. Recent innovations have involved the Hypoglycaemia Hotline, which was recognised in the Guardian Healthcare Awards 2013.
He is also the co-creator of TAD talks (Talking About Diabetes) and the Type 1 Diabetes comic (“Origins”)- while also involved in setting up a Type 1 Diabetes information portal (T1resources.uk)
He is also Associate National Clinical Director, Diabetes with NHS England leading on developing the NHS RightCare Diabetes pathway; leading on Freestyle Libre being available on NHS tariff and helping to coordinate the development of the Diabetes “Language Matters” document
Dr Jen Nash is a Clinical Psychologist and Chartered Associate Fellow of the British Psychological Society. She specialises in diabetes and weight and is the author of Diabetes and Wellbeing and Your Weight Isn’t About Food. Jen is an Editorial Board Member of the Journal of Diabetes Nursing.
She was named an “Outstanding Educator” Finalist in the Quality in Care Awards 2014 and was awarded the honour of a “World Diabetes Day Hero” in 2012 by the International Diabetes Federation. Jen has been living with type 1 diabetes since childhood and is a recovered emotional eater. She is the founder of Positive Diabetes and the Eating Blueprint™ (www.EatingBlueprint.com) online educational services for people with type 1 and type 2 diabetes and healthcare professionals.
Philip Newland-Jones is a Consultant Pharmacist in Diabetes and Endocrinology and works at University Hospitals Southampton NHS Foundation Trust. He is a member of the UKCPA Diabetes and Endocrinology Committee and Chairs the regional Diabetic subgroup of the District Prescribing Committee. At Southampton he takes a leading role in the trusts patient improvement framework for diabetes with numerous patient safety projects previously undertaken and ongoing.
At a national level he is the lead pharmacist for NHS England Diabetes and Endocrinology Clinical Reference Group, is a member of the Diabetes UK professional council and sits on the Diabetes Parliamentary Think Tank. He is also an editorial board member of “Diabetes in Primary Care”, the “Journal of Medicines Optimisation” and “Medicine Matters diabetes”. He is also a specialist advisor to the CQC for diabetes in secondary and intermediate care services. In 2015 he was awarded the National Leadership in Pharmacy award by the Royal Pharmaceutical Society.
He has a key role with pharmaceutical and clinical input into the direction of inpatient and outpatient diabetes care at University Hospital Southampton, and works in a Consultant practitioner prescribing Pharmacist role on a day to day basis reviewing inpatients and outpatients with diabetes and endocrine issues. His dedication to education ensures the rest of his time is taken up educating doctors, nurses, allied healthcare professionals and students within secondary care, primary care and university settings. He is the MSc module lead for “Modern Management of Diabetes, Nutrition and Pharmacotherapy” at the University of Southampton.
Fixing Dad is a documentary about an ordinary family's battle with type 2 diabetes. The original documentary has been viewed by 1.5 million people across the UK and is considered by many to be an example of the journey a patient can take. It explores how a patient can become engaged with their diabetes and ultimately, has the potential to change the course of their disease.